Phase 3, randomized trial (CheckMate 017) of nivolumab (nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Rechamp, K.; Spigel, D. R.; Rizvi, N.; Poddubskaya, E.; West, H.; Eberhardt, W.; Baas, P.; Antonia, S. J.; Pluzanski, A.; Vokes, E. E.; Holgado, E.; Waterhouse, D.; Reddy, N.; Gainor, J.; Frontera, O. A.; Horn, L.; Paz-Ares, L.; Zhu, J.; Lynch, M.; Brahmer, J. |
| Abstract Title: | Phase 3, randomized trial (CheckMate 017) of nivolumab (nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) |
| Meeting Title: | COSA's 42nd Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 11 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2015 Nov 17-19 |
| Meeting Location: | Hobart, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-11-01 |
| Start Page: | 130 |
| Language: | English |
| ACCESSION: | WOS:000364320800190 |
| PROVIDER: | wos |
| PUBMED: | 26525766 |
| DOI: | 10.1111/ajco.12432_2 |
| Notes: | Meeting Abstract: 214 -- Source: Wos |
